|
Federal
Register Notices > Notices
of Application - 2001 > Cerilliant
Corporation
[Federal Register: December 20, 2001 (Volume 66,
Number 245)]
[Notices]
[Page 65744-65746]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr20de01-73]
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Application
Pursuant to §1301.33(a) of Title 21 of the
Code of Federal Regulations (CFR), this is notice that on August 17, 2001, Cerilliant
Corporation, 14050 Summit Drive #121, P.O. Box 201088, Austin, Texas 78708-0189, made application by renewal to the Drug Enforcement
Administration (DEA) for registration as bulk manufacturer of the basic classes of controlled substances listed below:
|
Drug |
Schedule |
|
Cathinone (1235) |
I |
|
Methcathinone (1237) |
I |
| N-Ethylamphetamine (1475) |
I |
|
N, N-Dimethylamphetamine (1480) |
I |
|
Aminorex (1585) |
I |
|
4-Methylaminorex (cis isomer) (1590) |
I |
|
Gamma hydroxybutyric acid (2010) |
I |
|
Methaqualone (2565) |
I |
| Alpha-Ethyltryptamine (7249) |
I |
|
Lysergic acid diethylamide (7315) |
I |
|
Tetrahydrocannabinols (7370) |
I |
|
Mescaline (7381) |
I |
|
3, 4, 5-Trimethoxyamphetamine (7390) |
I |
|
4-Bromo-2, 5-dimethoxyaphetamine (7391) |
I |
|
4-Bromo-2, 5-dimethoxphenethylamine (7392) |
I |
|
4-Methyl-2, 5-dimethoxyamphetamine (7395) |
I |
|
2, 5-Dimethoxyamphetamine (7396) |
I |
|
2, 5-Dimethoxy-4-ethylamphetamie (7399) |
I |
|
3, 4-Methylenedioxyamphetamine (7400) |
I |
|
5-Methoxy-3, 4-methylenedioxyamphetamine (7401) |
I |
|
N-Hydroxy-3, 4-methylenedioxyamphetamine (7402) |
I |
|
3, 4-Methylenedioxy-N-ethylamphetamine (7404) |
I |
|
3, 4-Methylenedioxymethamphetamine (7405) |
I |
|
4-Methoxyamphetamine (7411) |
I |
[[Page 65745]]
| Drug |
Schedule |
| Bufotenine (7433) |
I |
|
Diethyltryptamine (7434) |
I |
|
Dimethyltryptamine (7435) |
I |
|
Psilocybin (7437) |
I |
|
Psilocyn (7438) |
I |
|
Acetyldihydrocodeine (9051) |
I |
|
Benzylmorphine (9052) |
I |
|
Codeine-N-oxide (9053) |
I |
|
Dihydromorphine (9145) |
I |
|
Heroin (9200) |
I |
|
Hydromorphinol (9301) |
I |
|
Methyldihydromorphine (9304) |
I |
| Morphone-N-oxide (9307) |
I |
|
Normorphine (9313) |
I |
|
Pholcodine (9314) |
I |
|
Acetylmethadol (9601) |
I |
|
Allyprodine (9602) |
I |
|
Alphacetylmethadol except Levo-Alphacetylmethadol (9603) |
I |
| Alphameprodine (9604) |
I |
|
Alphamethadol (9605) |
I |
|
Betacetylmethadol (9607) |
I |
|
Betameprodine (9608) |
I |
|
Betamethadol (9609) |
I |
|
Betaprodine (9611) |
I |
|
Hydromorphinol (9627) |
I |
|
Noracymethadol (9633) |
I |
|
Norlevorphanol (9634) |
I |
|
Normethadone (9635) |
I |
|
Trimeperidine (9646) |
I |
|
Phenomorphan (9647) |
I |
| Para-Fluorofentanyl (9812) |
I |
|
3-Methylfentanyl (9813) |
I |
| Alpha-methylfentanyl (9814) |
I |
| Acetyl-alpha-methylfentanyl
(9815) |
I |
| Beta-hydroxyfentanyl (9830) |
I |
|
Beta-hydroxy-3-methylfentanyl (9831) |
I |
| Alpha-Methylthiofentianyl
(9832) |
I |
|
3-Methylthiofentanyl (9833) |
I |
|
Thiofentanyl (9835) |
I |
|
Amphetamine (1100) |
II |
|
Methamphetamine (1105) |
II |
|
Phenmetrazine (1631) |
II |
|
Methylphenidate (1724) |
II |
|
Amobarbital (2125) |
II |
|
Pentobarbital (2270) |
II |
|
Secobarbital (2315) |
II |
|
Glutethimide (2550) |
II |
|
Nabilone (7379) |
II |
|
1-Phenylcyclohexylamine (7460) |
II |
|
Phencyclidine (7471) |
II |
|
1-Piperidinocyclohexanecarbonitrile (8603) |
II |
|
Alphaprodine (9010) |
II |
|
Cocaine (9041) |
II |
|
Codeine (9050) |
II |
|
Dihydrocodeine (9220) |
II |
|
Oxycodone (9143) |
II |
|
Hydromorphone (9150) |
II |
|
DIphenoxylate (9170) |
II |
|
Benzoylecgonine (9180) |
II |
|
Ethylmorphine (9190) |
II |
|
Hydrocodone (9193) |
II |
|
Levomethorphan (9210) |
II |
|
Levorphanol (9200) |
II |
|
Isomethadone (9226) |
II |
|
Meperidine (9230) |
II |
|
Methadone (9250) |
II |
|
Methadone-intermediate (9254) |
II |
|
Dextropropoxyphene, bulk (non-dosage forms) (9273) |
II |
|
Morphine (9300) |
II |
|
Thebaine (9333) |
II |
|
Levo-alphacetylmethadol (9648) |
II |
|
Oxymorphone (9652) |
II |
|
Noroxymorphone (9668) |
II |
|
Racemethorphane (9732) |
II |
[[Page 65746]]
|
Drug |
Schedule |
| Alfentanil (9737) |
II |
|
Sufentanil (9740) |
II |
|
Fentanyl (9801) |
II |
The firm plans to manufacture small quantities of
the listed controlled substances to make deuterated and non-deuterated drug
reference standards which will be distributed to analytical and forensic laboratories for drug testing programs.
Any other such applicant and any person who is presently registered
with DEA to manufacture such substance may file comments or objections to the issuance of the proposed registration.
Any such comments or objections may be addressed, in
quintuplicate, to the Deputy Assistance Administrator, Office of Diversion Control,
Drug Enforcement Administration, United States Department of Justice, Washington, DC 20537, Attention: DEA Federal Register Representative
(CCR), and must be filed no later than
February 19, 2002.
Dated: November 16, 2001.
Laura M. Nagel,
Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration.
[FR Doc. 01-31280 Filed
12-19-01; 8:45 am]
BILLING CODE 4410-09-M
NOTICE: This is an
unofficial version. An official version of these publications may be obtained
directly from the Government Printing Office (GPO).
Back to
Top
Registration
Support
Toll Free Number: 1-800-882-9539
ARCOS
| Career Opportunities | Chemical Program |
Controlled
Substance Schedules | Drugs and
Chemicals of Concern
Electronic Commerce Initiatives | | Federal Register
Notices | Import Export | Links
| Meetings
and Events | NFLIS
Offices &
Directories | On-Line Forms & Applications |
Program
Description | Publications
|
Questions & Answers | Quotas
Reports Required by 21 CFR | Title 21 Regulations & Codified
CSA
Contact Us | Home
| Hot
Items | Site Map | Search | What's New
|
